deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 7-arm NCT03158389

NCT Neuro Master Match - N²M² (NOA-20) (N²M²)

Umbrella Protocol for Phase I/IIa Trials of Molecularly Matched Targeted Therapies Plus Radiotherapy in Patients With Newly Diagnosed Glioblastoma Without MGMT Promoter Methylation: NCT Neuro Master Match - N²M² (NOA-20)

Sponsor: German Cancer Aid

Updated 8 times since 2017 Last updated: Sep 27, 2023 Started: May 7, 2018 Primary completion: Feb 22, 2023 Completion: Feb 22, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Glioblastoma, Adult, this trial is completed. The trial is conducted by German Cancer Aid and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Mar 2020 · 21 months · monthly snapshotRecruiting~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotRecruiting~Jan 2021 – ~Jun 2022 · 17 months · monthly snapshotRecruiting~Jun 2022 – ~Oct 2023 · 16 months · monthly snapshotRecruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2PHASE1/PHASE2

  3. Oct 2023 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

    Status: RecruitingCompleted

  4. Jun 2022 — Oct 2023 [monthly]

    Recruiting PHASE1_PHASE2

  5. Jan 2021 — Jun 2022 [monthly]

    Recruiting PHASE1_PHASE2

Show 3 earlier versions
  1. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

  2. Jun 2018 — Mar 2020 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet RecruitingRecruiting

  3. Jun 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • German Cancer Aid
  • German Cancer Research Center
  • National Center for Tumor Diseases, Heidelberg
  • University Hospital Heidelberg
Data source: University Hospital Heidelberg

For direct contact, visit the study record on ClinicalTrials.gov .